The largest database of trusted experimental protocols

Dig labelling mix

Manufactured by Merck Group
Sourced in United States

The DIG labelling mix is a reagent used in molecular biology techniques such as in situ hybridization and northern blotting. It contains digoxigenin-labeled nucleotides that can be incorporated into DNA or RNA probes, allowing for the detection of specific target sequences.

Automatically generated - may contain errors

3 protocols using dig labelling mix

1

Comprehensive IgLON expression analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each IgLON member, digoxigenin-labeled cRNA probes with either antisense or sense orientation were prepared by in vitro transcription using DIG labelling mix (Sigma,USA). Probe sequences were PCR-amplified from cDNAs prepared from mouse brain cDNA using primers designed based on sequences from the Allen Brain Atlas and Gene Paint Database (see Supplemental Material for probe sequences) and cloned into a pBluescript vector. cRNA probes were designed to detect expression of both the 1a and 1b transcripts for IgLON1, IgLON2, and IgLON3. Following in vitro transcription, the riboprobes were partially hydrolyzed in a 10 mM DTT and 200 mM NaHCO3/Na2CO3 solution (pH 11) for 25 min at 60 °C79 (link). Hydrolysis was stopped by addition of 100 mM acetic acid, and cRNA probes were precipitated by addition of 1/10th volume 4 M LiCl and ethanol. Precipitated cRNA fragments were resuspended in diethylpyrocarbonate (DEPC)-treated water and stored at − 80 °C.
+ Open protocol
+ Expand
2

Time-course analysis of Bra1 expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hydra polyps were treated with target inhibitors for 8 h and decapitated. After decapitation, the inhibitor treatment continued until the target time points of 1, 2, 4, and 8 hpa. The polyps were then relaxed by treatment with 2% urethane/HM for 2 min and fixed using 4% PFA/HM at 4°C overnight. Digoxigenin-labelled RNA probes for Hv_Bra1 were prepared by in vitro transcriptions from templates amplified from a recombinant pCR Blunt II TOPO (Cat # 450031; Invitrogen) plasmid containing the Hv_Bra1 gene using PCR. (DIG Labelling Mix, Cat # 1277073910; Sigma-Aldrich; SP6 RNA Polymerase, Cat # 10810274001; Sigma-Aldrich; T7 RNA Polymerase, Cat # 10881767001; Sigma-Aldrich). Whole-mount in situ hybridization was performed on the polyps as described previously (Martinez et al, 1997 (link)) with the following changes. Treatment with proteinase-K was performed for 5 min, and heat inactivation of the endogenous alkaline phosphatases was done at 70°C for 15 min in 1X SSC. Digoxigenin-labelled RNA probe at a concentration of 150 ng/ml was used for hybridization at 59°C. The post-hybridization washes were performed using 1X SSC-HS gradients. After staining with 50% NTMT/50% BM-purple AP substrate for 1 h at room temperature, the animals were mounted in 80% glycerol for imaging.
+ Open protocol
+ Expand
3

Murine Angptl2 Antisense Probe Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
pBlueScript SK ( + ) vector (Addgene #212205) containing the target DNA sequence for murine Angptl2—subcloned using EcoRI/HindIII restriction sites between the T3 and T7 promoters—was linearized with the restriction enzyme MluI (R3198S, New England Biolabs) and purified through silica membrane spin columns (20021, Qiagen). The synthesis of a 980 bp anti-sense probe was then realized with 500 ng of linearized DNA incubated with DIG labelling mix (11277073910, Sigma) and T3 polymerase (M0378S, New England Biolabs). The transcription product was further treated with DNase (74204, Qiagen) to clear the probe from all residual DNA. The RNA probe was then purified through a G-50 column (CA95017-623L, Amersham) and stored at −30 °C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!